Skip to content
Open access

Investigating the association between COVID-19 exposure and fetal and maternal health before public health vaccinations: A retrospective cohort study.

Sep 2026 · Public Health · Vol 260, pp. 106446 · 0 citations · 35 references
Medicine

Abstract

Objectives

Pregnant women and neonates face a higher risk of adverse outcomes from infectious diseases, such as COVID-19. COVID-19 vaccines were developed rapidly, but we do not fully understand how the disease affected pregnancies and births before these vaccines were available. This study investigated how COVID-19 impact on pregnant women and their neonates before vaccines became widely available. The aim was to investigate the association between maternal COVID-19 infection and pregnancy and neonatal outcomes. STUDY

Design

This retrospective cohort study included pregnant women and their neonates (n = 3472 each) in Mashhad before the COVID-19 vaccine rollout.

Methods

Participants were categorized into two groups: those who had COVID-19 and those who did not. Chi-square, t-tests, and Fisher's exact test were used to compare the groups. Linear and logistic regression analyses were used to examine the associations between COVID-19 exposure and different outcomes, both before and after adjusting for potential confounders.

Results

Pregnant women with COVID-19, when compared to those without, experienced less weight gain (OR = 0.91, CI 95%: 0.82-0.93) and shorter pregnancy duration (OR = 0.95, CI 95%: 0.92-0.97). COVID-19 infection in pregnant women also showed links to higher odds of cesarean (OR = 1.72, CI 95%: 1.62-1.83), gestational diabetes (OR = 1.11, CI 95%: 1.007-1.22), and unusual newborns that had congenital abnormalities (OR = 1.46, CI 95%: 1.03-2.11).

Conclusion

The study indicates that women who had COVID-19 during pregnancy, before vaccines were available, had a higher risk of adverse maternal and neonatal outcomes. This finding can provide useful information to healthcare providers and pregnant women about how COVID-19 vaccination can reduce the severity of illness and adverse maternal and neonatal outcomes during pregnancy and the postnatal period.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.